SPECTATOR: Perfusion Monitoring Before, During and After Lower Extremity Revascularization With Laser Speckle Contrast Imaging
- Vascular Disease，Peripheral
At a glance
- Phase
- Phase not stated
- Study type
- Observational
- Sponsor
- Leiden University Medical Center
- Enrolment target
- 30
- Started
- September 2026
- Main results due
- May 2028
- Study sites
- 1
- Registry updated
- 23 September 2026
Can you take part?
- Aged 18 years and over.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: * Scheduled for lower-extremity revascularization * Undergoing pre- and postoperative indocyanine near-infrared fluorescence perfusion measurements Exclusion Criteria: Any condition that the investigator considers to be potentially jeopardizing the patient's wellbeing or the study objectives
What this study is about
In the sponsor’s own words, from the registry.
This study aims to evaluate the feasibility of Laser Speckle Contrast Imaging for perioperative perfusion assessment of the lower extremity before, during, and after revascularization.
Study sites(1)
Leiden University Medical Center
Leiden, South Holland, Netherlands
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT07558174. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me